BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Bee venom inhibits the proliferation and migration of cervical-cancer cells in an HPV E6/E7-dependent manner

  • Kim, Da-Hyun (Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine) ;
  • Lee, Hyun-Woo (Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine) ;
  • Park, Hyun-Woo (Department of Biochemistry, College of Life Science, Yonsei University) ;
  • Lee, Han-Woong (Department of Biochemistry, College of Life Science, Yonsei University) ;
  • Chun, Kyung-Hee (Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine)
  • Received : 2020.02.12
  • Accepted : 2020.02.17
  • Published : 2020.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Bee venom (BV), secreted from the venom gland of the honey bee, contains several biological active compounds. BV has been widely used as a traditional medicine for treating human disease, including cancer. In this study, we have shown the molecular mechanism underlying the therapeutic effect of BV on cancer. Treatment with BV reduced the proliferation of cervical-cancer cells in a dose- and time-dependent manner. Interestingly, the killing effect of BV was specific to HPV-positive cervical-cancer cell lines, such as Caski and HeLa cells, and not to HPV-negative cervical-cancer cells (C33A). BV reduced the expression of HPV E6 and E7 at RNA and protein levels, leading to an increase in the expression of p53 and Rb in Caski and HeLa cells. Further, BV decreased the levels of cell-cycle proteins, such as cyclin A and B, and increased the levels of cell-cycle inhibitors, such as p21 and p27. BV significantly induced apoptosis and inhibited wound healing and migration of cervical-cancer cells. It also upregulated the expression of pro-apoptotic BAX and downregulated the expression of anti-apoptotic Bcl-2 and Bcl-XL. Cleavage of caspase-3, caspase-9, and PARP were also induced by BV treatment, whereas the phosphorylation of mitogenic signaling-related proteins, such as AKT, JNK, p38, and ERK, were downregulated. Our results indicate that BV has a therapeutic selectivity for HPV-positive malignant cells, so further clinical studies are needed to assess its clinical application.

Keywords

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394-424 https://doi.org/10.3322/caac.21492
  2. Hwang LY, Ma Y, Shiboski SC, Farhat S, Jonte J and Moscicki AB (2012) Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women. J Infect Dis 206, 504-511 https://doi.org/10.1093/infdis/jis398
  3. Marth C, Landoni F, Mahner S et al (2017) Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28, iv72-iv83 https://doi.org/10.1093/annonc/mdx220
  4. Tomao F, Santangelo G, Musacchio L et al (2020) Targeting cervical cancer: Is there a role for poly (ADPribose) polymerase inhibition? J Cell Physiol 6, 5050-5058
  5. Chaisakul J, Hodgson WC, Kuruppu S and Prasongsook N (2016) Effects of animal venoms and toxins on hallmarks of cancer. J Cancer 7, 1571-1578 https://doi.org/10.7150/jca.15309
  6. Hossen MS, Shapla UM, Gan SH and Khalil MI (2017) Impact of bee venom enzymes on diseases and immune responses. Molecules 22, 25 https://doi.org/10.3390/molecules22010025
  7. Kim YS, Jun H, Chae Y et al (2005) The practice of Korean medicine: An overview of clinical trials in acupuncture. Evid Based Complement Alternat Med 2, 325-352 https://doi.org/10.1093/ecam/neh102
  8. Kim YW, Chaturvedi PK, Chun SN, Lee YG and Ahn WS (2015) Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Oncol Rep 33, 1675-1682 https://doi.org/10.3892/or.2015.3760
  9. Walboomers JMM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-19 https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  10. Cyprian FS, Al-Farsi HF, Vranic S, Akhtar S and Al Moustafa AE (2018) Epstein-Barr virus and human papillomaviruses interactions and their roles in the initiation of epithelialmesenchymal transition and cancer progression. Front Oncol 8, 111 https://doi.org/10.3389/fonc.2018.00111
  11. Yao YL, Tian QF, Cheng B, Cheng YF, Ye J and Lu WG (2017) Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women. J Zhejiang Univ Sci B 18, 256-262
  12. Orsolic N (2012) Bee venom in cancer therapy. Cancer Metastasis Rev 31, 173-194 https://doi.org/10.1007/s10555-011-9339-3
  13. Rady I, Siddiqui IA, Rady M and Mukhtar H (2017) Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett 402, 16-31 https://doi.org/10.1016/j.canlet.2017.05.010
  14. Hong JJ, Lu XM, Deng ZX, Xiao SF, Yuan B and Yang K (2019) How melittin inserts into cell membrane: conformational changes, Inter-Peptide Cooperation, and Disturbance on the Membrane. Molecules 24, 1775 https://doi.org/10.3390/molecules24091775
  15. Liu SJ, Yu M, He Y et al (2008) Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology 47, 1964-1973 https://doi.org/10.1002/hep.22240
  16. Yim EK and Park JS (2005) The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat 37, 319-324 https://doi.org/10.4143/crt.2005.37.6.319
  17. Lipari F, McGibbon GA, Wardrop E and Cordingley MG (2001) Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein. Biochemistry 40, 1196-1204 https://doi.org/10.1021/bi001837+
  18. Crook T, Tidy JA and Vousden KH (1991) Degradation of P53 can be targeted by Hpv E6 sequences distinct from those required for P53 binding and transactivation. Cell 67, 547-556 https://doi.org/10.1016/0092-8674(91)90529-8
  19. Naseri MH, Mahdavi M, Davoodi J, Tackallou SH, Goudarzvand M and Neishabouri SH (2015) Up regulation of Bax and down regulation of Bcl2 during 3-NC mediated apoptosis in human cancer cells. Cancer Cell Int 15, 55 https://doi.org/10.1186/s12935-015-0204-2
  20. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655-1657 https://doi.org/10.1126/science.296.5573.1655
  21. Sarbassov DD, Ali SM and Sabatini DM (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17, 596-603 https://doi.org/10.1016/j.ceb.2005.09.009
  22. Weston CR and Davis RJ (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19, 142-149 https://doi.org/10.1016/j.ceb.2007.02.001
  23. Tournier C, Dong C, Turner TK, Jones SN, Flavell RA and Davis RJ (2001) MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev 15, 1419-1426 https://doi.org/10.1101/gad.888501
  24. Koul HK, Pal M and Koul S (2013) Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer 4, 342-359 https://doi.org/10.1177/1947601913507951
  25. Cuadrado A and Nebreda AR (2010) Mechanisms and functions of p38 MAPK signalling. Biochemical J 429, 403-417 https://doi.org/10.1042/BJ20100323
  26. Koul HK and Khandrika L (2008) Signal transduction targets in prostate cancer. Curr Signal Transduct Ther 3, 112-128 https://doi.org/10.2174/157436208784223143
  27. Lee HW, Jang KS, Choi HJ, Jo A, Cheong JH and Chun KH (2014) Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy. BMB Rep 47, 697-702 https://doi.org/10.5483/BMBRep.2014.47.12.069
  28. Kang HG, Kim WJ, Kang HG, Chun KH and Kim SJ (2019) Galectin-3 Interacts with C/EBPbeta and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer. Mol Cancer Res 18, 403-413 https://doi.org/10.1158/1541-7786.mcr-19-0811
  29. Cho Y, Kang HG, Kim SJ et al (2018) Post-translational modification of OCT4 in breast cancer tumorigenesis. Cell Death Differ 25, 1781-1795 https://doi.org/10.1038/s41418-018-0079-6
  30. Baek JH, Kim NJ, Song JK and Chun KH (2017) Kahweol inhibits lipid accumulation and induces Glucose-uptake through activation of AMP-activated protein kinase (AMPK). BMB Rep 50, 566-571 https://doi.org/10.5483/BMBRep.2017.50.11.031
  31. Kim SJ, Lee HW, Baek JH et al (2016) Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer. Oncogene 35, 251-260 https://doi.org/10.1038/onc.2015.80
  32. Kim SJ, Choi IJ, Cheong TC et al (2010) Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 138, 1035-1045 https://doi.org/10.1053/j.gastro.2009.09.061
  33. Kim NJ, Baek JH, Lee J, Kim H, Song JK and Chun KH (2019) A PDE1 inhibitor reduces adipogenesis in mice via regulation of lipolysis and adipogenic cell signaling. Exp Mol Med 51, 5 https://doi.org/10.1038/s12276-018-0198-7